Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EHT 0202 in mild to moderate Alzheimer's disease
NCT00880412Phase 2Completed
- Sponsor
- ExonHit Therapeutics
- Start
- Apr 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etazolate in Alzheimer's disease (AD), sponsored by ExonHit Therapeutics. Started Apr 2008; status: completed.
02
Drugs
etazolate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00880412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880412.